EDGEWISE THERAPEUTICS, INC. 8-K

Company

Edgewise Therapeutics, Inc.

Filed

November 10, 2021

Period of Report

November 10, 2021

Accession Number

0001157523-21-001387

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →